TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 0 | -2 | -4 | -24 | -41 | -59 | -22 |
| P | %wins | 67 | 33 | 33 | 0 | 0 | 0 | 22 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/2/17 17:17 | 7/31/17 | ONCS | Oncosec Medical Inc | NV | Health | Drug | Pharmaceutical Preparations | Mohan-Peterson Sheela | CA | O | Chief Le | P | 3 | 0.8800 | 0 | 3 | 46 | 10 | D | ||||||||||||||
2/2/17 20:45 | 1/31/17 | ONCS | Oncosec Medical Inc | NV | Health | Drug | Pharmaceutical Preparations | Mohan-Peterson Sheela | CA | O | Chief Le | P | 3 | 0.9900 | 0 | 3 | 85 | 7 | D | -84 | -30 | -36 | -41 | -12 | -13 | -9 | -6 | -1 | 13 | 25 | -4 | ||
8/5/16 16:15 | 7/31/16 | ONCS | Oncosec Medical Inc | NV | Health | Drug | Pharmaceutical Preparations | Mohan-Peterson Sheela | CA | O | CL,CO | P | 4 | 1.44 | 0 | 3 | 2 | 153 | D | -74 | -66 | 12 | 14 | 19 | 19 | 9 | 3 | 1 | -12 | -11 | -2 | -38 | |
10/19/15 10:28 | 10/16/15 | ONCS | Oncosec Medical Inc | NV | Health | Drug | Pharmaceutical Preparations | Mohan-Peterson Sheela | CA | O | GC | P | 2 | 4.24 | 1 | 1 | New | 1 | D | -23 | -50 | -30 | -28 | -26 | -25 | 6 | 4 | 1 | -6 | -26 | -65 | -44 | -59 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |